3,381
Views
54
CrossRef citations to date
0
Altmetric
Original Articles

Health-related quality of life in prostate cancer

, , , , &
Pages 1094-1101 | Received 25 Oct 2012, Accepted 15 Dec 2012, Published online: 01 Feb 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Deepika Reddy, Marieke van Son, Max Peters, Mariana Bertoncelli Tanaka, Tim Dudderidge, Emma Cullen, Carmen Lok Tung Ho, Richard G. Hindley, Amr Emara, Stuart McCracken, Clement Orczyk, Iqbal Shergill, Stephen Mangar, Raj Nigam, Jaspal Virdi, Caroline M. Moore, Manit Arya, Taimur T. Shah, Mathias Winkler, Mark Emberton, Alison Falconer, Jonathan Belsey & Hashim U. Ahmed. (2023) Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis. Journal of Medical Economics 26:1, pages 1099-1107.
Read now
Tomasz Jurys, Bartlomiej Burzynski, Anna Potyka & Andrzej Paradysz. (2022) Post-Radical Prostatectomy Erectile Dysfunction Assessed Using the IIEF-5 Questionnaire – A Systematic Literature Review. International Journal of Sexual Health 34:1, pages 55-64.
Read now
Jyri-Pekka Koskinen, Niilo Färkkilä, Harri Sintonen, Tiina Saarto, Kimmo Taari & Risto P. Roine. (2019) The association of financial difficulties and out-of-pocket payments with health-related quality of life among breast, prostate and colorectal cancer patients. Acta Oncologica 58:7, pages 1062-1068.
Read now
Andrew Wood, Sejal Barden, Mitchell Terk & Jamie Cesaretti. (2019) Prostate cancer: the influence of stigma on quality of life and relationship satisfaction for survivors and their partners. Journal of Psychosocial Oncology 37:3, pages 350-366.
Read now
Andrew W. Wood, Sejal Barden, Mitchell Terk & Jamie Cesaretti. (2017) The influence of stigma on the quality of life for prostate cancer survivors. Journal of Psychosocial Oncology 35:4, pages 451-467.
Read now
Susanne Bergius, Saku Torvinen, Timo Muhonen, Risto P. Roine, Harri Sintonen & Kimmo Taari. (2017) Health-related quality of life among prostate cancer patients: real-life situation at the beginning of treatment. Scandinavian Journal of Urology 51:1, pages 13-19.
Read now
Saku Torvinen, Niilo Färkkilä, Risto P. Roine, Harri Sintonen, Tiina Saarto & Kimmo Taari. (2016) Costs in different states of prostate cancer. Acta Oncologica 55:1, pages 30-37.
Read now
Niilo Färkkilä, Saku Torvinen, Harri Sintonen, Tiina Saarto, Heikki Järvinen, Juha Hänninen, Kimmo Taari & Risto P. Roine. (2015) Costs of colorectal cancer in different states of the disease. Acta Oncologica 54:4, pages 454-462.
Read now

Articles from other publishers (46)

Eun Mi Lee, Paula Jiménez-Fonseca, Raquel Hernández, Patricia Cruz-Castellanos, Ana Fernández-Montes, Jacobo Rogado, Mireia Gil-Raga, Mónica Antoñanzas, Helena López-Ceballos & Caterina Calderon. (2023) The Role of Financial Difficulties as a Mediator between Physical Symptoms and Depression in Advanced Cancer Patients. Current Oncology 30:6, pages 5719-5726.
Crossref
Norma B. Bulamu, Christine Mpundu-Kaambwa, Michael O’Callaghan & Billingsley Kaambwa. (2023) Responsiveness and construct validity of EPIC-26, AQoL-6D and SF-6D following treatment in prostate cancer. BMC Cancer 23:1.
Crossref
Rachel Song, Varinder Jeet, Rajan Sharma, Martin Hoyle & Bonny Parkinson. (2022) Cost-Effectiveness Analysis of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) for the Primary Staging of Prostate Cancer in Australia. PharmacoEconomics 40:8, pages 807-821.
Crossref
Seon-Ha Kim, Minsu Ock, Min-Woo Jo & Sungchan Park. (2022) Estimation of Utility Weights for Prostate-related Health States in Korea. Journal of Preventive Medicine and Public Health 55:3, pages 243-252.
Crossref
Mahsa Aghajani Mir, Hossein Dinmohammadi, Emadoddin Moudi, Nima Motamed & Abdolreza Daraei. (2022) Clinical values of expression signature of circCDR1AS and circHIAT1 in prostate cancer: Two circRNAs with regulatory function in androgen receptor (AR) and PI3K/AKT signaling pathways. Journal of Clinical Laboratory Analysis 36:2.
Crossref
Edna Keeney, Howard Thom, Emma Turner, Richard M. Martin, Josie Morley & Sabina Sanghera. (2022) Systematic Review of Cost-Effectiveness Models in Prostate Cancer: Exploring New Developments in Testing and Diagnosis. Value in Health 25:1, pages 133-146.
Crossref
Edward Morcos, Christian Falconer, Emilie Toresson Grip, Kirk Geale, Katarina Hellgren, Georgios Poutakidis & Daniel Altman. (2021) Association between surgical volumes and real-world healthcare cost when using a mesh capturing device for pelvic organ prolapse: A 5-years comparison between single- versus multicenter use. International Urogynecology Journal 32:11, pages 3007-3015.
Crossref
Sophia Kristina Rupp & Andreas Stengel. (2021) Influencing Factors and Effects of Treatment on Quality of Life in Patients With Gastric Cancer—A Systematic Review. Frontiers in Psychiatry 12.
Crossref
Anne M. Rentz, Sonal G. Mansukhani, Jinan Liu, Andrew J. Lloyd, Sebastian Heidenreich, Louis S. Matza, Nancy A. Dawson, Neal Shore & Stephen J. Freedland. (2021) Patients’ preferences for delaying metastatic castration-resistant prostate cancer: Combining health state and treatment valuation. Urologic Oncology: Seminars and Original Investigations 39:6, pages 367.e7-367.e17.
Crossref
Lauren Matheson, Jo Nayoan, Carol Rivas, Jo Brett, Penny Wright, Hugh Butcher, Paul Jordan, Anna Gavin, Adam Glaser, Malcolm Mason, Richard Wagland & Eila Watson. (2020) Strategies for living well with hormone-responsive advanced prostate cancer—a qualitative exploration. Supportive Care in Cancer 29:3, pages 1317-1325.
Crossref
Mathieu Gauthé, Kevin Zarca, Cyrielle Aveline, Frédéric Lecouvet, Sona Balogova, Olivier Cussenot, Jean-Noël Talbot & Isabelle Durand-Zaleski. (2020) Comparison of 18F-sodium fluoride PET/CT, 18F-fluorocholine PET/CT and diffusion-weighted MRI for the detection of bone metastases in recurrent prostate cancer: a cost-effectiveness analysis in France. BMC Medical Imaging 20:1.
Crossref
Malou C.P. Kuppen, Hans M. Westgeest, Alphonsus J.M. van den Eertwegh, Jules L.L.M. Coenen, Reindert J.A. van Moorselaar, Pieter van den Berg, Maud M. Geenen, Niven Mehra, Mathijs P. Hendriks, Menuhin I. Lampe, Addy C.M. van de Luijtgaarden, Frank P.J. Peters, Ton A. Roeleveld, Tineke J. Smilde, Ronald de Wit, Inge M. van Oort, Winald R. Gerritsen & Carin A. Uyl-de Groot. (2020) Health-related Quality of Life and Pain in a Real-world Castration-resistant Prostate Cancer Population: Results From the PRO-CAPRI Study in the Netherlands. Clinical Genitourinary Cancer 18:3, pages e233-e253.
Crossref
Thomas van Gelder, Brendan Mulhern, Dounya Schoormans, Olga Husson & Richard De Abreu Lourenço. (2020) Assessing health-related quality of life in cancer survivors: factors impacting on EORTC QLU-C10D-derived utility values. Quality of Life Research 29:6, pages 1483-1494.
Crossref
Maurizio Brausi, Peter Hoskin, Elisabeth Andritsch, Ian Banks, Marc Beishon, Helen Boyle, Maurizio Colecchia, Roberto Delgado-Bolton, Michael Höckel, Kay Leonard, József Lövey, Pablo Maroto, Ken Mastris, Rui Medeiros, Peter Naredi, Raymond Oyen, Theo de Reijke, Peter Selby, Tiina Saarto, Riccardo Valdagni, Alberto Costa & Philip Poortmans. (2020) ECCO Essential Requirements for Quality Cancer Care: Prostate cancer. Critical Reviews in Oncology/Hematology 148, pages 102861.
Crossref
Simon Chowdhury, Stéphane Oudard, Hiroji Uemura, Steven Joniau, Dominic Pilon, Patrick Lefebvre, Kelly McQuarrie, Jinan Liu, Lindsay Dearden, Jan Sermon, Suzy Van Sanden, Joris Diels & Boris A. Hadaschik. (2019) Matching-Adjusted Indirect Comparison of Health-Related Quality of Life and Adverse Events of Apalutamide Versus Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer. Advances in Therapy 37:1, pages 512-526.
Crossref
Dzung Ngoc Thi Dang, Lan Ngoc Thi Nguyen, Nga Thi Dang, Huy Quang Dang & Thanh Van Ta. (2019) Quality of Life in Vietnamese Gastric Cancer Patients. BioMed Research International 2019, pages 1-9.
Crossref
Kristiina Pynnä, Piia Vuorela, Pasi Aronen, Harri Sintonen, Tarja Vainiola, Arto Leminen, Risto P Roine & Pirjo Räsänen. (2019) Treatment of gynecological malignancies: long-term follow-up of health-related quality of life and healthcare costs. Journal of Comparative Effectiveness Research 8:7, pages 475-486.
Crossref
Amy Downing, Penny Wright, Luke Hounsome, Peter Selby, Sarah Wilding, Eila Watson, Richard Wagland, Paul Kind, David W Donnelly, Hugh Butcher, James W F Catto, William Cross, Malcolm Mason, Linda Sharp, David Weller, Galina Velikova, Eilis McCaughan, Rebecca Mottram, Majorie Allen, Therese Kearney, Oonagh McSorley, Dyfed W Huws, David H Brewster, Emma McNair, Anna Gavin & Adam W Glaser. (2019) Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study. The Lancet Oncology 20:3, pages 436-447.
Crossref
Anne Magnus, Wanrudee Isaranuwatchai, Cathrine Mihalopoulos, Victoria Brown & Rob Carter. (2019) A Systematic Review and Meta-Analysis of Prostate Cancer Utility Values of Patients and Partners Between 2007 and 2016. MDM Policy & Practice 4:1, pages 238146831985233.
Crossref
Daniel Altman, Kirk Geale, Christian Falconer & Edward Morcos. (2018) A generic health-related quality of life instrument for assessing pelvic organ prolapse surgery: correlation with condition-specific outcome measures. International Urogynecology Journal 29:8, pages 1093-1099.
Crossref
Eeva Harju, Anja Rantanen, Mika Helminen, Marja Kaunonen, Taina Isotalo & Päivi Åstedt‐Kurki. (2018) Marital relationship and health‐related quality of life of patients with prostate cancer and their spouses: A longitudinal clinical study. Journal of Clinical Nursing 27:13-14, pages 2633-2639.
Crossref
Nuno Nobre, Marco Pereira, Risto P. Roine, Jussi Sutinen & Harri Sintonen. (2018) HIV-Related Self-Stigma and Health-Related Quality of Life of People Living With HIV in Finland. Journal of the Association of Nurses in AIDS Care 29:2, pages 254-265.
Crossref
Guillemette Emma Benoist, Inge M. van Oort, Stella Smeenk, Adrian Javad, Diederik M. Somford, David M. Burger, Niven Mehra & Nielka P. van Erp. (2018) Drug-drug interaction potential in men treated with enzalutamide: Mind the gap. British Journal of Clinical Pharmacology 84:1, pages 122-129.
Crossref
Rita Faria, Marta O. Soares, Eldon Spackman, Hashim U. Ahmed, Louise C. Brown, Richard Kaplan, Mark Emberton & Mark J. Sculpher. (2018) Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging: A Cost-effectiveness Analysis Based on the Prostate MR Imaging Study (PROMIS). European Urology 73:1, pages 23-30.
Crossref
Eeva Harju, Anja Rantanen, Marja Kaunonen, Mika Helminen, Taina Isotalo & Päivi Åstedt-Kurki. (2017) The health-related quality of life of patients with prostate cancer and their spouses before treatment compared with the general population. International Journal of Nursing Practice 23:5, pages e12572.
Crossref
I. López-Calderero, L. López-Fando, E. Ríos-González, P. Maisonobe, E. Hernández-Yuste & M. Sarmiento-Jordán. (2017) Impact of locally advanced or metastatic prostate cancer on the quality of life. Actas Urológicas Españolas (English Edition) 41:6, pages 368-375.
Crossref
I. L?pez-Calderero, L. L?pez-Fando, E. R?os-Gonz?lez, P. Maisonobe, E. Hern?ndez-Yuste & M. Sarmiento-Jord?n. (2017) Impacto del c?ncer de pr?stata localmente avanzado/metast?sico en la calidad de vida. Actas Urol?gicas Espa?olas 41:6, pages 368-375.
Crossref
M B Hannouf, E Winquist, S M Mahmud, M Brackstone, S Sarma, G Rodrigues, P Rogan, J S Hoch & G S Zaric. (2016) Cost-effectiveness of using a gene expression profiling test to aid in identifying the primary tumour in patients with cancer of unknown primary. The Pharmacogenomics Journal 17:3, pages 286-300.
Crossref
Hiten Naik, Doris Howell, Susie Su, Xin Qiu, M. Catherine Brown, Ashlee Vennettilli, Margaret Irwin, Vivien Pat, Hannah Solomon, Tian Wang, Henrique Hon, Lawson Eng, Mary Mahler, Henry Thai, Valerie Ho, Wei Xu, Soo Jin Seung, Nicole Mittmann & Geoffrey Liu. (2016) EQ-5D Health Utility Scores: Data from a Comprehensive Canadian Cancer Centre. The Patient - Patient-Centered Outcomes Research 10:1, pages 105-115.
Crossref
K. Aro, L. Bäck, V. Loimu, K. Saarilahti, S. Rogers, H. Sintonen, R. Roine & Antti Mäkitie. (2015) Trends in the 15D health-related quality of life over the first year following diagnosis of head and neck cancer. European Archives of Oto-Rhino-Laryngology 273:8, pages 2141-2150.
Crossref
Ima Paydar, Robyn A. Cyr, Thomas M. Yung, Siyuan Lei, Brian Timothy Collins, Leonard N. Chen, Simeng Suy, Anatoly Dritschilo, John H. Lynch & Sean P. Collins. (2016) Proctitis 1 Week after Stereotactic Body Radiation Therapy for Prostate Cancer: Implications for Clinical Trial Design. Frontiers in Oncology 6.
Crossref
Marieke H.J. van den Beuken-van Everdingen, Laura M.J. Hochstenbach, Elbert A.J. Joosten, Vivianne C.G. Tjan-Heijnen & Daisy J.A. Janssen. (2016) Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis. Journal of Pain and Symptom Management 51:6, pages 1070-1090.e9.
Crossref
Giuseppe Colloca & Pasquale Colloca. (2015) The Effects of Social Support on Health-Related Quality of Life of Patients with Metastatic Prostate Cancer. Journal of Cancer Education 31:2, pages 244-252.
Crossref
Michael C. Repka, Shan Guleria, Robyn A. Cyr, Thomas M. Yung, Harsha Koneru, Leonard N. Chen, Siyuan Lei, Brian T. Collins, Pranay Krishnan, Simeng Suy, Anatoly Dritschilo, John Lynch & Sean P. Collins. (2016) Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction. Frontiers in Oncology 6.
Crossref
Camilla Andersson, Birgitta Johansson, Cecilia Wassberg, Silvia Johansson, Anders Sundin & Håkan Ahlström. (2016) Assessment of Whether Patients’ Knowledge, Satisfaction, and Experience Regarding Their 18 F-Fluoride PET/CT Examination Affects Image Quality . Journal of Nuclear Medicine Technology 44:1, pages 21-25.
Crossref
Saku Torvinen, Susanne Bergius, Risto Roine, Leena Lodenius, Harri Sintonen & Kimmo Taari. (2016) USE OF PATIENT ASSESSED HEALTH-RELATED QUALITY OF LIFE INSTRUMENTS IN PROSTATE CANCER RESEARCH: A SYSTEMATIC REVIEW OF THE LITERATURE 2002–15. International Journal of Technology Assessment in Health Care 32:3, pages 97-106.
Crossref
Andrew J. Lloyd, Cicely Kerr, James Penton & Gerhart Knerer. (2015) Health-Related Quality of Life and Health Utilities in Metastatic Castrate-Resistant Prostate Cancer: A Survey Capturing Experiences from a Diverse Sample of UK Patients. Value in Health 18:8, pages 1152-1157.
Crossref
V. Loimu, A. A. Mäkitie, L. J. Bäck, H. Sintonen, P. Räsänen, R. Roine & K. Saarilahti. (2014) Health-related quality of life of head and neck cancer patients with successful oncological treatment. European Archives of Oto-Rhino-Laryngology 272:9, pages 2415-2423.
Crossref
Teresa Sequeira, Pedro Lopes Ferreira, Joana Teixeira, Isabel Peres, Jorge Oliveira & Augusta Silveira. (2015) Patient-Reported Outcomes in Prostate Cancer: Prospective Changes Analysis for Prognosis Prediction. Journal of Cancer Therapy 06:15, pages 1238-1248.
Crossref
Sang-Young Roh, Hye-A. Yeom, Myung-Ah Lee & In Young Hwang. (2014) Mobility of older palliative care patients with advanced cancer: A Korean study. European Journal of Oncology Nursing 18:6, pages 613-618.
Crossref
S. Henninger, S. Neusser, C. Lorenz & E.M. Bitzer. (2014) Prostatakarzinom in der RoutineversorgungProstate cancer in routine healthcare. Der Urologe 53:12, pages 1793-1799.
Crossref
M?nica ?vila, Yolanda Pardo, Manel Castells, Ferran Ferrer, Ana Boladeras, Joan Pera, Pedro J. Prada, Benjamin Guix, Belen de Paula, Helena Hernandez, Angels Pont, Jordi Alonso, Olatz Garin, Karen Bremner, Murray Krahn & Montse Ferrer. (2014) Adaptation and validation of the Spanish version of the Patient-Oriented Prostate Utility Scale (PORPUS). Quality of Life Research 23:9, pages 2481-2487.
Crossref
Hee-Ju Kim, Patrick S. Malone & Andrea M. Barsevick. (2014) Subgroups of Cancer Patients With Unique Pain and Fatigue Experiences During Chemotherapy. Journal of Pain and Symptom Management 48:4, pages 558-568.
Crossref
Amy K. Silberbogen, Andrea K. Busby & Erin W. Ulloa. (2013) Impact of Psychological Distress on Prostate Cancer Screening in U.S. Military Veterans. American Journal of Men's Health 8:5, pages 399-408.
Crossref
Niilo Färkkilä, Saku Torvinen, Risto P. Roine, Harri Sintonen, Juha Hänninen, Kimmo Taari & Tiina Saarto. (2013) Health-related quality of life among breast, prostate, and colorectal cancer patients with end-stage disease. Quality of Life Research 23:4, pages 1387-1394.
Crossref
John D. Graham. 2014. Prostate Cancer. Prostate Cancer 287 297 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.